Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...

Lung carcinoma is the most commonly diagnosed cancer and the leading cause of cancer deaths in the ... Figure 5: Age-adjusted prevalence of smoking among African Americans and whites aged 18 ...

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

Doctors treating lung cancer cases in countries or societies where people smoke a lot of cigarettes will realize the debilitating consequences of tobacco smoke on human health. Tobacco smoke is one of ...

The U.S. Food and Drug Administration has approved GSK plc (NYSE:GSK)’s asthma medication, Nucala, for expanded use in ...

Eligible patients with previously untreated, metastatic squamous non–small-cell lung cancer (NSCLC) were randomly assigned ... subsequent PD after next line of treatment or death from any cause) was ...

In fact, smoking is the leading cause of preventable cancer and is responsible for a significant number of cancer-related deaths each year. About half of U.S. deaths caused by certain cancers -- ...

Lung cancer can affect anyone; however, smoking is responsible for the vast majority (approximately 90%) of cases. The second-largest cause of lung cancer is exposure to radon, a naturally occurring ...

Breast cancer is the second leading cause of cancer death in women. (Only lung cancer kills more women each year.) The chance that any woman will die from breast cancer is about 1 in 43 (about 2.3%).

smoking cessation tobacco and The lung tobacco control Lung cancer is a preventable form of cancer with approximately 90% of cases attributable to cumulative tobacco exposure.1 Smoking cessation and ...

Many Black and Latina women are regularly using beauty products which contain cancer-causing chemicals — and not just in hair straightening products, a new study reveals. The study was based on ...

“We just don’t know what is causing this concerning increase in ... potentially lower your risk,” explains Yale Early Onset Cancer Program Co-Founder Dr. Nancy Borstelmann.